Bacil Pharma Statistics
Total Valuation
Bacil Pharma has a market cap or net worth of INR 242.14 million. The enterprise value is 287.62 million.
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bacil Pharma has 14.35 million shares outstanding. The number of shares has decreased by -11.03% in one year.
| Current Share Class | 14.35M |
| Shares Outstanding | 14.35M |
| Shares Change (YoY) | -11.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 56.95% |
| Owned by Institutions (%) | n/a |
| Float | 6.12M |
Valuation Ratios
The trailing PE ratio is 19.67.
| PE Ratio | 19.67 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 36.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.24 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.91 |
Financial Efficiency
Return on equity (ROE) is 3.04% and return on invested capital (ROIC) is -0.67%.
| Return on Equity (ROE) | 3.04% |
| Return on Assets (ROA) | -0.40% |
| Return on Invested Capital (ROIC) | -0.67% |
| Return on Capital Employed (ROCE) | -0.72% |
| Weighted Average Cost of Capital (WACC) | 4.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 3.92M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.33% in the last 52 weeks. The beta is 0.14, so Bacil Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -45.33% |
| 50-Day Moving Average | 20.86 |
| 200-Day Moving Average | 36.02 |
| Relative Strength Index (RSI) | 31.43 |
| Average Volume (20 Days) | 15,137 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.82M |
| Pretax Income | 1.15M |
| Net Income | 7.85M |
| EBITDA | n/a |
| EBIT | -1.82M |
| Earnings Per Share (EPS) | 0.86 |
Full Income Statement Balance Sheet
The company has 9.74 million in cash and 55.22 million in debt, with a net cash position of -45.48 million or -3.17 per share.
| Cash & Cash Equivalents | 9.74M |
| Total Debt | 55.22M |
| Net Cash | -45.48M |
| Net Cash Per Share | -3.17 |
| Equity (Book Value) | 252.21M |
| Book Value Per Share | 20.96 |
| Working Capital | 13.29M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bacil Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 11.03% |
| Shareholder Yield | 11.03% |
| Earnings Yield | 5.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |